L.McGowanB.MosenzonO.PedersenS
The HGF II with a flexible N-K1-K2-K3 fragment might be able to recruit a third c-MET through the K1SEMA interaction
Saxenda had significant annual sales of $165 million as of June 2025, indicating a substantial market opportunity for Teva's generic version
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
With its powerful antioxidant action, pigmentation control and skin-brightening properties, Glutathione offers visible yet gentle results over time
In other words: yes, were closer than ever to brain-health breakthroughs